Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19
| Errataetall: |
CommentIn: Ann Rheum Dis. 2021 Apr;80(4):e54. - PMID 32475831 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:79 |
|---|---|
| Enthalten in: |
Annals of the rheumatic diseases - 79(2020), 10 vom: 09. Okt., Seite 1386-1388 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Konig, Maximilian F [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
4QWG6N8QKH |
|---|
| Anmerkungen: |
Date Completed 24.09.2020 Date Revised 04.05.2023 published: Print-Electronic CommentIn: Ann Rheum Dis. 2021 Apr;80(4):e54. - PMID 32475831 Citation Status MEDLINE |
|---|
| doi: |
10.1136/annrheumdis-2020-217690 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM309648378 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM309648378 | ||
| 003 | DE-627 | ||
| 005 | 20231225134358.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/annrheumdis-2020-217690 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1032.xml |
| 035 | |a (DE-627)NLM309648378 | ||
| 035 | |a (NLM)32381561 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Konig, Maximilian F |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.09.2020 | ||
| 500 | |a Date Revised 04.05.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Ann Rheum Dis. 2021 Apr;80(4):e54. - PMID 32475831 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a epidemiology | |
| 650 | 4 | |a hydroxychloroquine | |
| 650 | 4 | |a lupus erythematosus, systemic | |
| 650 | 4 | |a pharmacokinetics | |
| 650 | 7 | |a Antirheumatic Agents |2 NLM | |
| 650 | 7 | |a Hydroxychloroquine |2 NLM | |
| 650 | 7 | |a 4QWG6N8QKH |2 NLM | |
| 700 | 1 | |a Kim, Alfred Hj |e verfasserin |4 aut | |
| 700 | 1 | |a Scheetz, Marc H |e verfasserin |4 aut | |
| 700 | 1 | |a Graef, Elizabeth R |e verfasserin |4 aut | |
| 700 | 1 | |a Liew, Jean W |e verfasserin |4 aut | |
| 700 | 1 | |a Simard, Julia |e verfasserin |4 aut | |
| 700 | 1 | |a Machado, Pedro M |e verfasserin |4 aut | |
| 700 | 1 | |a Gianfrancesco, Milena |e verfasserin |4 aut | |
| 700 | 1 | |a Yazdany, Jinoos |e verfasserin |4 aut | |
| 700 | 1 | |a Langguth, Daman |e verfasserin |4 aut | |
| 700 | 1 | |a Robinson, Philip C |e verfasserin |4 aut | |
| 700 | 0 | |a COVID-19 Global Rheumatology Alliance |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of the rheumatic diseases |d 1939 |g 79(2020), 10 vom: 09. Okt., Seite 1386-1388 |w (DE-627)NLM000174114 |x 1468-2060 |7 nnns |
| 773 | 1 | 8 | |g volume:79 |g year:2020 |g number:10 |g day:09 |g month:10 |g pages:1386-1388 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/annrheumdis-2020-217690 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 79 |j 2020 |e 10 |b 09 |c 10 |h 1386-1388 | ||